Dr. Cugno joined Sidra in 2014, where she covers the double role of Director of the Advanced Cell Therapy Core and Attending Physician in Pediatric Oncology and Hematology.

 

She is a 20-year experienced medical doctor with a Board Certification in Pediatrics and Pediatric Hematology/Oncology at the University of Pavia (Italy), and a Master in Pediatric Hematology at the University “La Sapienza”, Rome (Italy).

 

In Italy, she has been directly involved in the Hematopoietic Stem Cell Transplantation (HSCT) activities at the Pediatric Hematology/Oncology Unit, Fondazione IRCCS Policlinico San Matteo, a renowned Academic Health Center that has performed more than 2000 transplantations.

 

At Sidra, Dr. Cugno has been working on the development of the Advanced Cell Therapy Core, including a Cellular Therapy Unit for the delivery of cellular products for tissue, cell and gene therapy, and a Clinical Trial Office.

 

Activities currently range from Hematopoietic Stem Cells processing, as part of the Bone Marrow Transplantation clinical program, to several projects of cell therapy (i.e. production of mesenchymal stromal cell from different sources), gene therapy (i.e. gene therapy approaches in Hemophilia) and regenerative medicine (i.e. production of platelet rich plasma, platelet rich fibrin, adipose-derived stem cells and cell-drug codelivery).

Dr. Cugno is also the Editorial Board member of Journal of Translational Medicine.